# The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

> **NCT00960713** · — · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 35 (actual)

## Conditions studied

- Pemphigus
- Auto-immune Thrombocytopenic Purpura
- Hemolytic Auto-immune Anaemia
- Cold Agglutinin Disease
- Cryoglobulinemia

## Interventions

- **DRUG:** Rituximab (MABTHERA® or RITUXAN®).

## Key facts

- **NCT ID:** NCT00960713
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2012-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00960713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00960713, "The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00960713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*